About the event

Held over a weekend, the event is structured around a series of exhibitions, workshops, and panel discussions. The exhibitions showcase a curated selection of photographs that tell compelling stories from various corners of the globe, each image accompanied by detailed narratives that provide context and deeper insight into the historical significance of the scenes depicted. These photographs are drawn from the archives of renowned photographers, as well as emerging talents, ensuring a blend of both classical and contemporary perspectives.

Cliff Palace, Colorado
Investor’s Delight: Creative Medical Technology Holdings Inc (CELZ) Closes Weak at 2.67, Down -2.55 – DwinneX

Investor’s Delight: Creative Medical Technology Holdings Inc (CELZ) Closes Weak at 2.67, Down -2.55

Abby Carey

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

The closing price of Creative Medical Technology Holdings Inc (NASDAQ: CELZ) was $2.67 for the day, down -2.55% from the previous closing price of $2.74. In other words, the price has decreased by -$2.55 from its previous closing price. On the day, 83669.0 shares were traded. CELZ stock price reached its highest trading level at $2.79 during the session, while it also had its lowest trading level at $2.58.

Ratios:

Our analysis of CELZ’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 20.70 and its Current Ratio is at 20.71. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 19 ’25 when Finger Michael H. sold 750 shares for $5.75 per share. The transaction valued at 4,312 led to the insider holds 351 shares of the business.

Finger Michael H. sold 750 shares of CELZ for $3,750 on Feb 18 ’25. The Director now owns 1,101 shares after completing the transaction at $5.00 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CELZ now has a Market Capitalization of 6890020 and an Enterprise Value of 1528703. For the stock, the TTM Price-to-Sale (P/S) ratio is 688.94 while its Price-to-Book (P/B) ratio in mrq is 1.23. Its current Enterprise Value per Revenue stands at 254.784 whereas that against EBITDA is -0.256.

Stock Price History:

The Beta on a monthly basis for CELZ is 5.88, which has changed by 0.028142571 over the last 52 weeks, in comparison to a change of 0.12159383 over the same period for the S&P500. Over the past 52 weeks, CELZ has reached a high of $6.90, while it has fallen to a 52-week low of $1.69. The 50-Day Moving Average of the stock is -21.11%, while the 200-Day Moving Average is calculated to be -11.52%.

Shares Statistics:

CELZ traded an average of 85.62K shares per day over the past three months and 120810 shares per day over the past ten days. A total of 2.58M shares are outstanding, with a floating share count of 2.55M. Insiders hold about 1.37% of the company’s shares, while institutions hold 2.74% stake in the company. Shares short for CELZ as of 1763078400 were 43224 with a Short Ratio of 0.50, compared to 1760486400 on 52198. Therefore, it implies a Short% of Shares Outstanding of 43224 and a Short% of Float of 1.7000000000000002.

Earnings Estimates

At present, 1.0 analysts are actively evaluating the performance of Creative Medical Technology Holdings Inc (CELZ) in the stock market. Analysts are recommending an EPS of between -$2.03 and -$2.03 for the fiscal current year, implying an average EPS of -$2.03. EPS for the following year is -$1.39, with 1.0 analysts recommending between -$1.39 and -$1.39.

Revenue Estimates

A total of 1 analysts have provided revenue estimates for CELZ’s current fiscal year. The highest revenue estimate was $3k, while the lowest revenue estimate was $3k, resulting in an average revenue estimate of $3k. In the same quarter a year ago, actual revenue was $11k

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.